NCT01202786View on ClinicalTrials.gov

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

April 30, 2012

Conditions
Neoplasms, Unknown Primary
Trial Locations (3)

49100

Rabin Medical Center, Petah Tikva

Unknown

Ha'emek Medical Center, Afula

Soroka Medical Center, Beersheba

Sponsors
All Listed Sponsors
collaborator

Clalit Health Services

OTHER

collaborator

Rosetta Genomics

UNKNOWN

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY